Breast imaging technology: Application of magnetic resonance imaging to angiogenesis in breast cancer
暂无分享,去创建一个
[1] Rankin Sc,et al. MRI of the breast. , 2000 .
[2] H. Degani,et al. Response of MCF7 human breast cancer to tamoxifen: evaluation by the three-time-point, contrast-enhanced magnetic resonance imaging method. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[3] A R Padhani,et al. Probing tumor microvascularity by measurement, analysis and display of contrast agent uptake kinetics , 1997, Journal of magnetic resonance imaging : JMRI.
[4] P J Drew,et al. Microvessel density in invasive breast cancer assessed by dynamic gd‐dtpa enhanced MRI , 1997 .
[5] L D Buadu,et al. Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis. , 1996, Radiology.
[6] D B Kopans,et al. Dynamic echo-planar imaging of the breast: experience in diagnosing breast carcinoma and correlation with tumor angiogenesis. , 1997, Radiology.
[7] Scott Fields,et al. Mapping pathophysiological features of breast tumors by MRI at high spatial resolution , 1997, Nature Medicine.
[8] David A. Cheresh,et al. Detection of tumor angiogenesis in vivo by αvβ3-targeted magnetic resonance imaging , 1998, Nature Medicine.
[9] R. Gilles,et al. Ductal carcinoma in situ: MR imaging-histopathologic correlation. , 1995, Radiology.
[10] T. Ishibashi,et al. [Magnetic resonance imaging of breast cancer: correlation between contrast enhancement and tumor angiogenesis]. , 1999, Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica.
[11] A R Padhani,et al. MRIW: parametric analysis software for contrast-enhanced dynamic MR imaging in cancer. , 1998, Radiographics : a review publication of the Radiological Society of North America, Inc.
[12] S. Rankin,et al. MRI of the breast. , 2000, The British journal of radiology.
[13] R. Warren,et al. Magnetic resonance imaging screening in women at genetic risk of breast cancer: imaging and analysis protocol for the UK multicentre study , 2000 .
[14] N. van Bruggen,et al. Magnetic resonance imaging detects suppression of tumor vascular permeability after administration of antibody to vascular endothelial growth factor. , 1998, Cancer investigation.
[15] S G Orel. MR imaging of the breast. , 2000, Radiologic clinics of North America.
[16] C. Kuhl,et al. MRI of breast tumors , 2000, European Radiology.
[17] M. Bednarski,et al. Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging. , 1998, Nature medicine.
[18] R. Weissleder,et al. In vivo assessment of vascular endothelial growth factor‐induced angiogenesis , 1999, International journal of cancer.
[19] R. Paola,et al. Correlation Between Contrast Enhancement in Dynamic Magnetic Resonance Imaging of the Breast and Tumor Angiogenesis , 1994, Investigative radiology.
[20] M. Knopp,et al. Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols , 1999, Journal of magnetic resonance imaging : JMRI.
[21] G Brix,et al. Pathophysiologic basis of contrast enhancement in breast tumors , 1999, Journal of magnetic resonance imaging : JMRI.
[22] J. Folkman,et al. The role of angiogenesis in tumor growth. , 1992, Seminars in cancer biology.
[23] H. Degani,et al. Dynamic contrast-enhanced magnetic resonance imaging reveals stress-induced angiogenesis in MCF7 human breast tumors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.